Abiopharma

News list

ECB BANCORP, INC. /MD/ (ECBK)

SEC News
April 23, 2026, 20:07 UTC

(99% Neutral) ECB BANCORP, INC. /MD/ (ECBK) Reports Q2 2026 Financial Results

Full text

News bot April 23, 2026, 8:10 p.m.

📋 ECB BANCORP, INC. /MD/ (ECBK) - Financial Results

Filing Date: 2026-04-23

Accepted: 2026-04-23 16:07:09

Event Type: Financial Results

Event Details:

ECB BANCORP, INC. /MD/ (ECBK) Reports the reporting period Financial Results ECB BANCORP, INC. /MD/ (ECBK) announced its financial results for the period ending the reporting period. Key Financial Highlights:

Revenue: 36
Net Income: 3122
EPS: 0.38
Cash and equivalents: 111291

📊 Key Financial Metrics (Year-over-Year Comparison):

Metric	2026	2025	Change ($)	Change (%)
Assets Other Assets	6.91K	20.00	$6.89K	+34470.00%

💼 Business Developments:

Partnership: Not available
Acquisition: Not available
Licensing
Regulatory Approval: Not available
Executive Changes: Not available

Structured Data:

Company Name: ECB BANCORP, INC. /MD/
Ticker Symbol: ECBK